NT-pro-BNP may thus be a potential marker of AF disease progression (e.g., arrhythmic burden and extent of atrial cardiomyopathy) or co-morbidities (such as heart failure) that may have an impact on the success rate after PVI [11]. Here, NPPB is linked to atrial fibrillation.